吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Oct 18 2022

Full Issue

White House Worries New Variants Could Beat Evusheld Preventive Drug

Stat reports on Biden administration health officials' concerns that AstraZeneca鈥檚 Evusheld, a monoclonal antibody drug that's become essential for immunocompromised Americans, could be bypassed by emerging variants. Meanwhile, the covid czar urges seniors to get new boosters.

Biden health officials are bracing for the prospect that the country鈥檚 sole preventive Covid-19 treatment for immunocompromised people could be ineffective this winter. (Owermohle, 10/18)

A top White House health official on Monday issued a stark warning to older people about the health risk they face this fall and winter from Covid-19. (Kimball, 10/17)

The most recent聽data聽from the European Centre for Disease Prevention and Control shows that cases began going up around the beginning of September in Europe. 聽The seven-day average is roughly 230,000 cases per day, reflecting rates that were seen in late July when Europe was still dealing with the omicron BA.4/BA.5 subvariant wave.聽(Choi, 10/17)

As winter inches closer, Dr. Fauci is sounding the alarm about a pair of 鈥減retty troublesome鈥 Covid variants. The two descendants of omicron鈥檚 BA.5 subvariant, called BQ.1 and BQ.1.1, both have dangerous 鈥渜ualities or characteristics that could evade some of the interventions we have,鈥 Fauci told CBS News on Friday. (Constantino, 10/17)

Official case numbers now represent 鈥渢he tip of the iceberg鈥 of actual infections, Denis Nash, an epidemiologist at the City University of New York, told me. Although case rates may seem low now, true infections may be up to 20 times higher. And even those case numbers are no longer available on a daily basis in many places, as the CDC and most state agencies have switched to updating their data once a week instead of every day. (Ladyzhets, 10/17)

California鈥檚 coronavirus emergency will officially end in February, Gov. Gavin Newsom announced Monday, nearly three years after the state鈥檚 first confirmed death from the disease prompted a raft of restrictions that upended public life. (Beam, 10/17)

And scientists are under fire for their work on a lab-made version of covid 鈥

Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus is garnering heated headlines alleging the scientists involved could have unleashed a new pathogen. (Branswell, 10/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF